---
figid: PMC9311918__antioxidants-11-01304-g001
figtitle: 'mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative
  Diseases'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9311918
filename: antioxidants-11-01304-g001.jpg
figlink: /pmc/articles/PMC9311918/figure/antioxidants-11-01304-f001/
number: F1
caption: 'The common mTOR signalling pathway in ocular neurodegenerative diseases.
  Abbreviations: AMP’, 5’ adenosine monophosphate-activated protein kinase; ATF4,
  activating transcription factor 4; ATG, autophagy-regulating protease; BNIP3L, adenovirus
  E1B 19 kDa protein-interacting protein 3-like; CHOP, C/EBP homologous protein; ER,
  endoplasmic reticulum; HIF-1α, hypoxia-inducible factor 1-alpha; HO-1, heme oxygenase-1;
  mTORC1, mammalian target of rapamycin complex 1; Nrf2, nuclear factor-erythroid
  factor 2-related factor 2; PERK, protein kinase R (PKR)-like endoplasmic reticulum
  kinase; PI3K, phosphoinositide 3-kinase; PINK1, PTEN-induced kinase 1; REDD1, regulated
  in development and DNA damage responses 1; Rheb, ras homolog enriched in brain;
  ROS, reactive oxygen species; TFEB, transcription factor EB; TSC, tuberous sclerosis
  complex; ULK1, unc-51-like kinase 1; VPS34, vacuolar protein sorting 34.'
papertitle: 'mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative
  Diseases.'
reftext: Yipin Wang, et al. Antioxidants (Basel). 2022 Jul;11(7):1304.
year: '2022'
doi: 10.3390/antiox11071304
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI
keywords: mTOR | AMD | DR | glaucoma | oxidative stress | hypoxia | inflammation |
  ROS | rapamycin | clinical trial
automl_pathway: 0.9056364
figid_alias: PMC9311918__F1
figtype: Figure
redirect_from: /figures/PMC9311918__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9311918__antioxidants-11-01304-g001.html
  '@type': Dataset
  description: 'The common mTOR signalling pathway in ocular neurodegenerative diseases.
    Abbreviations: AMP’, 5’ adenosine monophosphate-activated protein kinase; ATF4,
    activating transcription factor 4; ATG, autophagy-regulating protease; BNIP3L,
    adenovirus E1B 19 kDa protein-interacting protein 3-like; CHOP, C/EBP homologous
    protein; ER, endoplasmic reticulum; HIF-1α, hypoxia-inducible factor 1-alpha;
    HO-1, heme oxygenase-1; mTORC1, mammalian target of rapamycin complex 1; Nrf2,
    nuclear factor-erythroid factor 2-related factor 2; PERK, protein kinase R (PKR)-like
    endoplasmic reticulum kinase; PI3K, phosphoinositide 3-kinase; PINK1, PTEN-induced
    kinase 1; REDD1, regulated in development and DNA damage responses 1; Rheb, ras
    homolog enriched in brain; ROS, reactive oxygen species; TFEB, transcription factor
    EB; TSC, tuberous sclerosis complex; ULK1, unc-51-like kinase 1; VPS34, vacuolar
    protein sorting 34.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EIF2AK3
  - ATF4
  - BAK1
  - BAX
  - NFKB1
  - DDIT3
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GABPA
  - NFE2L2
  - HMOX1
  - TFEB
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - DDIT4
  - PIK3C3
  - TSC2
  - TSC1
  - CCL26
  - MTOR
  - RPTOR
  - RHEB
  - RHEBP1
  - ATG14
  - ATG13
  - BNIP3L
  - PINK1
---
